Bioanalysis of zosuquidar trihydrochloride (LY335979) in small volumes of human and murine plasma by ion-pairing reversed-phase high-performance liquid chromatography.
暂无分享，去创建一个
[1] J. Schellens,et al. Bioanalysis and preliminary pharmacokinetics of the acridonecarboxamide derivative GF120918 in plasma of mice and humans by ion-pairing reversed-phase high-performance liquid chromatography with fluorescence detection. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[2] Olaf van Tellingen,et al. The importance of drug-transporting P-glycoproteins in toxicology. , 2001 .
[3] A. Dantzig,et al. Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979. , 1996, Cancer research.
[4] D. Slate,et al. RS-33295-198: a novel, potent modulator of P-glycoprotein-mediated multidrug resistance. , 1995, Anticancer research.
[5] S. Wrighton,et al. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations. , 1998, Drug metabolism and disposition: the biological fate of chemicals.
[6] C. Shih,et al. Pharmacological characterization of LY335979: a potent cyclopropyldibenzosuberane modulator of P-glycoprotein. , 1997, Advances in enzyme regulation.